Status:
RECRUITING
Integrated Short-Term Palliative Rehabilitation in Incurable Cancer
Lead Sponsor:
King's College London
Collaborating Sponsors:
Hospices Civils de Lyon
University of Bergen
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this intervention trial is to determine if palliative rehabilitation in addition to usual care is more effective than usual care at improving health-related quality of life in patients wit...
Detailed Description
Background and study aims Cancer is one of the main causes of illness, burden and death in Europe. The Joint Research Centre (JRC) of the EU estimated 2.7 million new cancer cases. For all cancers, be...
Eligibility Criteria
Inclusion
- Aged 18 years or older.
- Diagnosis of incurable solid cancer: lung, colorectal, breast, prostate or other, irrespective of timing in relation to any oncology or palliative care treatments
- Eastern Cooperative Oncology Group performance status 2-3
- Able to provide informed consent and complete trial assessments in available languages.
Exclusion
- Blood cancers: Leukaemia, Lymphoma, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder (MPD), Multiple Myeloma.
- Currently receiving specialist rehabilitation\* for their cancer or co-morbidity-related dysfunction, or received within the two weeks prior to consent.
- Clinician rated prognosis of less than 3 months.
Key Trial Info
Start Date :
April 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT05984797
Start Date
April 18 2024
End Date
August 31 2026
Last Update
May 22 2024
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev Hospital
Herlev, Denmark, 2730
2
Hôpital Lyon Sud HCL
Lyon, France, 69002
3
Istituto Nazionale dei Tumori di Milano
Milan, Italy, 20133
4
AUSL di Reggio Emilia
Reggio Emilia, Italy, 42122